BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 30252690)

  • 1. Outcome Differences in Neonates Exposed In-Utero to Opioids Managed in the NICU Versus Pediatric Floor.
    Lembeck AL; Tuttle D; Locke R; Lawler L; Jimenez P; Mackley A; Paul DA
    J Addict Med; 2019; 13(1):75-78. PubMed ID: 30252690
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of Time to First Dose of Oral Morphine in the Treatment of Neonatal Abstinence Syndrome.
    Mitchell ST; Costello TJ; Nedderman KM
    Pharmacotherapy; 2017 Jul; 37(7):849-855. PubMed ID: 28500681
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A management strategy that reduces NICU admissions and decreases charges from the front line of the neonatal abstinence syndrome epidemic.
    Loudin S; Werthammer J; Prunty L; Murray S; Shapiro JI; Davies TH
    J Perinatol; 2017 Oct; 37(10):1108-1111. PubMed ID: 28682317
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The relationship between gestational age and the severity of neonatal abstinence syndrome.
    Gibson KS; Stark S; Kumar D; Bailit JL
    Addiction; 2017 Apr; 112(4):711-716. PubMed ID: 27886650
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Hospital-Level Intervention to Improve Outcomes of Opioid Exposed Newborns.
    Cree M; Jairath P; May O
    J Pediatr Nurs; 2019; 48():77-81. PubMed ID: 31352111
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antenatal methadone vs buprenorphine exposure and length of hospital stay in infants admitted to the intensive care unit with neonatal abstinence syndrome.
    Tolia VN; Murthy K; Bennett MM; Miller ES; Benjamin DK; Smith PB; Clark RH
    J Perinatol; 2018 Jan; 38(1):75-79. PubMed ID: 29048415
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neonatal abstinence outcomes in post-acute care: A brief report.
    O'Brien JE; Dumas HM; Leslie D
    J Pediatr Rehabil Med; 2015; 8(2):157-60. PubMed ID: 26409869
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Morphine vs Methadone Treatment for Infants with Neonatal Abstinence Syndrome.
    Tolia VN; Murthy K; Bennett MM; Greenberg RG; Benjamin DK; Smith PB; Clark RH
    J Pediatr; 2018 Dec; 203():185-189. PubMed ID: 30220442
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduction in Length of Stay and Morphine Use for NAS With the "Eat, Sleep, Console" Method.
    Blount T; Painter A; Freeman E; Grossman M; Sutton AG
    Hosp Pediatr; 2019 Aug; 9(8):615-623. PubMed ID: 31285356
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluating the effect of hospital setting on outcomes for neonatal abstinence syndrome.
    Grossman MR; Berkwitt AK; Osborn RR; Citarella BV; Hochreiter D; Bizzarro MJ
    J Perinatol; 2020 Oct; 40(10):1483-1488. PubMed ID: 32086436
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Retrospective chart review comparing morphine and methadone in neonates treated for neonatal abstinence syndrome.
    Young ME; Hager SJ; Spurlock D
    Am J Health Syst Pharm; 2015 Dec; 72(23 Suppl 3):S162-7. PubMed ID: 26582303
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hospital Variation in Neonatal Abstinence Syndrome Incidence, Treatment Modalities, Resource Use, and Costs Across Pediatric Hospitals in the United States, 2013 to 2016.
    Milliren CE; Gupta M; Graham DA; Melvin P; Jorina M; Ozonoff A
    Hosp Pediatr; 2018 Jan; 8(1):15-20. PubMed ID: 29263122
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treating Neonatal Abstinence Syndrome in a Rural Hospital: Lessons Learned.
    Gadomski A; Riley M; Ramiza K; Onofrey L; Zinkievich R; Krupa N; Scribani M
    Acad Pediatr; 2018; 18(4):425-429. PubMed ID: 29428413
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Incidence, risk factors, and outcome of neonatal acute kidney injury: a prospective cohort study.
    Shalaby MA; Sawan ZA; Nawawi E; Alsaedi S; Al-Wassia H; Kari JA
    Pediatr Nephrol; 2018 Sep; 33(9):1617-1624. PubMed ID: 29869723
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rooming-in for Infants at Risk for Neonatal Abstinence Syndrome: Outcomes 5 Years following Its Introduction as the Standard of Care at One Hospital.
    Newman AI; Mauer-Vakil D; Coo H; Newton L; Wilkerson E; McKnight S; Brogly SB
    Am J Perinatol; 2022 Jun; 39(8):897-903. PubMed ID: 33202425
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictors of mortality and length of stay for neonates admitted to children's hospital neonatal intensive care units.
    Berry MA; Shah PS; Brouillette RT; Hellmann J
    J Perinatol; 2008 Apr; 28(4):297-302. PubMed ID: 18046336
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neonatal Abstinence Syndrome: Influence of a Combined Inpatient/Outpatient Methadone Treatment Regimen on the Average Length of Stay of a Medicaid NICU Population.
    Lee J; Hulman S; Musci M; Stang E
    Popul Health Manag; 2015 Oct; 18(5):392-7. PubMed ID: 25803316
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predicting mortality and length-of-stay for neonatal admissions to private hospital neonatal intensive care units: a Southern African retrospective study.
    Pepler PT; Uys DW; Nel DG
    Afr Health Sci; 2012 Jun; 12(2):166-73. PubMed ID: 23056023
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of the triage process in neonatal intensive care.
    Zupancic JA; Richardson DK
    Pediatrics; 1998 Dec; 102(6):1432-6. PubMed ID: 9832581
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Home-based detoxification for neonatal abstinence syndrome reduces length of hospital admission without prolonging treatment.
    Smirk CL; Bowman E; Doyle LW; Kamlin O
    Acta Paediatr; 2014 Jun; 103(6):601-4. PubMed ID: 24547949
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.